Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Neurocrine Biosciences reports positive results from phase I/II malignant glioma trial

April 27, 2000

Campath MAA accepted for review by European authorities

April 26, 2000

Novelos Therapeutics initiates first U.S. trial of BAM-002

April 25, 2000

Coley initiates phase I/II trials of CpG-7909 for cancer

April 24, 2000

Preclinical results for Avax's AC Vaccine technology in breast cancer presented at AACR

April 14, 2000

SuperGen and AVI BioPharma establish marketing agreement for Avicine

April 11, 2000

Zadaxin plus chemotherapy shows promise in malignant melanoma

April 11, 2000

M-Vax shown to induce T-cell-mediated immune reactions in metastatic melanoma study

April 11, 2000

Dendreon describes preparation and use of apoptosis-inducing HLA-DR-specific MAbs

April 10, 2000

Health Canada approves Rituxan for treatment of NHL

April 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...